endocrinology
Type 1 diabetes

Intensive control ‘modestly’ extends life

Intensive control of blood glucose levels can modestly extend the lives of diabetes patients, a landmark 27 year follow up trial shows. The Diabetes Control and Complications Trial (DCCT) showed a 33% reduction in mortality among type 1 diabetes patients who maintained glycaemic control (HbA1c levels of around 7%) for an average of 6.5 years compared with ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic